Endobronchial Valve in Tubercular and NTM Pulmonary Cavities.

by palligoelme@gmail.com | Dec 22, 2025 | Clinical Trials

​ Conditions: Multidrug Resistance Tubercolosis; Non Tubercolar Micobacteriosis Interventions: Device: Endobronchial valves Sponsors: Azienda Ospedaliero-Universitaria Careggi Not yet recruiting Conditions: Multidrug Resistance Tubercolosis; Non Tubercolar...

Internet-Based Cognitive Behavioral Therapy for MRI-Related Anxiety

by palligoelme@gmail.com | Dec 22, 2025 | Clinical Trials

​ Conditions: Anxiety; Claustrophobia; Magnetic Resonance Imaging (MRI) Interventions: Behavioral: Intervention Sponsors: Johan Kihlberg; Linkoeping University; Region Östergötland; Region Jönköping County; Landstinget i Kalmar Län Recruiting Conditions: Anxiety;...

Association Between Vitamin D Deficiency and Inflammatory Bowel Disease

by palligoelme@gmail.com | Dec 22, 2025 | Clinical Trials

​ Conditions: Inflammatory Bowel Diseases Interventions: Diagnostic Test: Serum 25(OH)D (Vitamin D3), C- reactive protein, Erthrocyte sedimentation rate Sponsors: Assiut University Not yet recruiting Conditions: Inflammatory Bowel Diseases Interventions: Diagnostic...

Effects of Combined Posture Correction and Resistive Respiratory Muscles Training in COPD With FHP

by palligoelme@gmail.com | Dec 19, 2025 | Clinical Trials

​ Conditions: COPD – Chronic Obstructive Pulmonary Disease; Forward Head Posture Interventions: Device: Resistive inspiratory muscles training; Device: Resistive expiratory muscles training:; Device: Combined resistive inspiratory and expiratory muscles training...

Accelerating Recovery After ICU Admission: Post-discharge Supplementation With Pasteurized Akkermansia Muciniphila.

by palligoelme@gmail.com | Dec 19, 2025 | Clinical Trials

​ Conditions: Sepsis; Post Intensive Care Unit Syndrome; Critical Illness; Microbiome Dysbiosis; Intensive Care Unit Survivors Interventions: Dietary Supplement: Pasteurized Akkermansia muciniphila; Other: Placebo Control Sponsors: Academisch Medisch Centrum –...

A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late Onset Pompe Disease (PROGRESS-GT LOPD)

by palligoelme@gmail.com | Dec 19, 2025 | Clinical Trials

​ Conditions: Pompe Disease (Late-onset); Pompe Disease Late-Onset; LOPD Interventions: Genetic: AB-1009 (GAA Gene) Sponsors: AskBio Inc; Bayer Not yet recruiting Conditions: Pompe Disease (Late-onset); Pompe Disease Late-Onset; LOPD Interventions: Genetic: AB-1009...